Tag Archives: ACR 2020

The use of methotrexate is linked to increased risks of tuberculosis

[ad_1] Tuberculosis screening among patients receiving methotrexate in high risk areas is a highly unmet need in public health. In a new evaluation presented at the American College of Rheumatology (ACR) Convergence 2020, researchers from North America reported that methotrexate, a key element in the treatment of rheumatic diseases and …

Read More »